Signant Health and ActiGraph simplify clinical trial activity and sleep monitoring for patients, sites, and sponsors with their new integration
November 14, 2019 – Clinical Trials –
Philadelphia, PA – November 14, 2019: Signant Health,
formerly CRF Health and Bracket, is proud to announce that it has integrated
its industry leading eCOA platform TrialMax, with ActiGraphís CentrePoint system.
The integration, which includes ActiGraphís FDA 510(k) cleared sensors, helps simplify the process of
collecting and monitoring real-world activity, mobility, and sleep outcomes
data for patients and researchers.
formerly CRF Health and Bracket, is proud to announce that it has integrated
its industry leading eCOA platform TrialMax, with ActiGraphís CentrePoint system.
The integration, which includes ActiGraphís FDA 510(k) cleared sensors, helps simplify the process of
collecting and monitoring real-world activity, mobility, and sleep outcomes
data for patients and researchers.
The TrialMax and CentrePoint
system integration is yet another step pointing towards the growing importance of
measuring real-world patient functioning in clinical trials. Home-based
activity and sleep monitoring, measured using ActiGraphís research-grade
wearable devices, provides important insights into real-world functioning that
are applicable to drug development in a broad range of disease
indications. Many diseases adversely
affect activity and sleep, which ultimately impacts quality of life. Measuring treatment-related improvements in
free-living activity and sleep provides valuable and objective insight into the
aspect of treatment, and is essential in the study of sleep disorders, and also
a critical component used to assess patient quality of life in many other
conditions including pain, asthma, COPD, overactive bladder, cancer, and others.
system integration is yet another step pointing towards the growing importance of
measuring real-world patient functioning in clinical trials. Home-based
activity and sleep monitoring, measured using ActiGraphís research-grade
wearable devices, provides important insights into real-world functioning that
are applicable to drug development in a broad range of disease
indications. Many diseases adversely
affect activity and sleep, which ultimately impacts quality of life. Measuring treatment-related improvements in
free-living activity and sleep provides valuable and objective insight into the
aspect of treatment, and is essential in the study of sleep disorders, and also
a critical component used to assess patient quality of life in many other
conditions including pain, asthma, COPD, overactive bladder, cancer, and others.
Using multiple technologies in clinical trials can
complicate participation for sites and patients. Signant Health has developed
an integration with ActiGraphís FDA 510(k) cleared sensors to make practical
implementation easier for sites and patients and provide greater value from the
combination of wearable and eCOA data collected and aggregated using the
TrialMax platform.
complicate participation for sites and patients. Signant Health has developed
an integration with ActiGraphís FDA 510(k) cleared sensors to make practical
implementation easier for sites and patients and provide greater value from the
combination of wearable and eCOA data collected and aggregated using the
TrialMax platform.
The integration provides important efficiencies and
simplifies workflow for study sites. Patients are enrolled using Signant Healthís TrialMax eCOA platform, and
real-time integration with ActiGraphís CentrePoint platform means that all
enrolment activities are accomplished through the single TrialMax
interface. Sites and Sponsors can also
view activity and sleep parameters alongside patient-reported outcomes data
collected via TrialMax through Signant Healthís online reporting solution. In addition, data-driven notifications and
alerts can be triggered based on both the activity/sleep and eCOA data
collected using TrialMax – for example, providing reminders to patients to
encourage compliance if they have worn the ActiGraph device for less than the
requested number of hours per day.
simplifies workflow for study sites. Patients are enrolled using Signant Healthís TrialMax eCOA platform, and
real-time integration with ActiGraphís CentrePoint platform means that all
enrolment activities are accomplished through the single TrialMax
interface. Sites and Sponsors can also
view activity and sleep parameters alongside patient-reported outcomes data
collected via TrialMax through Signant Healthís online reporting solution. In addition, data-driven notifications and
alerts can be triggered based on both the activity/sleep and eCOA data
collected using TrialMax – for example, providing reminders to patients to
encourage compliance if they have worn the ActiGraph device for less than the
requested number of hours per day.
With this
integration, Signant Health continues to expand and support its promise to
offer the industry more patient-centric trial designs. Bill Byrom, Signant
Healthís VP Product Strategy & Innovation, said ‘Itís important that
patients continue to experience trials that benefit them without burdening
them. Using ActiGraphís devices not only provides a simple and efficient
experience for patients, it also simplifies and streamlines trials for sites
and sponsors while offering better data and insights.’
integration, Signant Health continues to expand and support its promise to
offer the industry more patient-centric trial designs. Bill Byrom, Signant
Healthís VP Product Strategy & Innovation, said ‘Itís important that
patients continue to experience trials that benefit them without burdening
them. Using ActiGraphís devices not only provides a simple and efficient
experience for patients, it also simplifies and streamlines trials for sites
and sponsors while offering better data and insights.’
Byrom added ‘Itís
also beneficial for compliance. The combination of ActiGraphís activity and
sleep monitoring with TrialMax eCOA enables proactive data-driven alerts and
notifications to sites and patients. We
believe this has the potential to reduce unusable data and improve data quality
when measuring real-world activity and sleep alongside patient-reported
outcomes in clinical trials’.
also beneficial for compliance. The combination of ActiGraphís activity and
sleep monitoring with TrialMax eCOA enables proactive data-driven alerts and
notifications to sites and patients. We
believe this has the potential to reduce unusable data and improve data quality
when measuring real-world activity and sleep alongside patient-reported
outcomes in clinical trials’.
Who Is Signant Health?
The best technology succeeds in the background.
Signant Health provides solutions that simplify every step of the study
participant journey to make it easier for people to participate in, and for
sites and study teams to run, clinical trials. Signant unites eCOA, eConsent,
Patient Engagement, IRT, Clinical Supplies and Endpoint Quality into the
industryís most comprehensive patient-centric suite – an evolution built on
more than 20 years of proven clinical research technology. Our intense focus on
the patient experience, deep therapeutic area expertise and global operational
scale enable hundreds of sponsors and CROs (including all Top 20 pharma) to
extend the reach of drug development, expand patient opportunities and improve
data quality – helping them bring life-changing therapies to our families and
communities around the world. Take a significant step toward patient-centricity
at signanthealth.com.
Signant Health provides solutions that simplify every step of the study
participant journey to make it easier for people to participate in, and for
sites and study teams to run, clinical trials. Signant unites eCOA, eConsent,
Patient Engagement, IRT, Clinical Supplies and Endpoint Quality into the
industryís most comprehensive patient-centric suite – an evolution built on
more than 20 years of proven clinical research technology. Our intense focus on
the patient experience, deep therapeutic area expertise and global operational
scale enable hundreds of sponsors and CROs (including all Top 20 pharma) to
extend the reach of drug development, expand patient opportunities and improve
data quality – helping them bring life-changing therapies to our families and
communities around the world. Take a significant step toward patient-centricity
at signanthealth.com.
CRF Health and Bracket are now Signant Health.
Contact: media@signanthealth.com, +1 267.498.2350
About ActiGraph
ActiGraph is a leading provider of
medical-grade physical activity and sleep monitoring solutions for the global
scientific community. ActiGraphís FDA-cleared wearable actigraphy monitors and
robust analytics platform have been widely used to quantify human movement in
academic and population health research for nearly two decades. In recent
years, the companyís monitoring solutions have been steadily adopted by
pharmaceutical and life sciences organizations seeking to capture real-world
objective outcomes related to physical activity, mobility, and sleep behaviour
for patients enrolled in clinical trials. For more information, visit www.actigraphcorp.com
medical-grade physical activity and sleep monitoring solutions for the global
scientific community. ActiGraphís FDA-cleared wearable actigraphy monitors and
robust analytics platform have been widely used to quantify human movement in
academic and population health research for nearly two decades. In recent
years, the companyís monitoring solutions have been steadily adopted by
pharmaceutical and life sciences organizations seeking to capture real-world
objective outcomes related to physical activity, mobility, and sleep behaviour
for patients enrolled in clinical trials. For more information, visit www.actigraphcorp.com
